DaVita Inc. (LON:0I7E)
Market Cap | 9.01B |
Revenue (ttm) | 10.24B |
Net Income (ttm) | 747.92M |
Shares Out | n/a |
EPS (ttm) | 8.57 |
PE Ratio | 12.05 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 243 |
Average Volume | 453 |
Open | 144.12 |
Previous Close | 145.47 |
Day's Range | 141.44 - 144.82 |
52-Week Range | 71.57 - 154.45 |
Beta | 0.93 |
RSI | 25.51 |
Earnings Date | Feb 10, 2025 |
About DaVita
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition... [Read more]
Financial Performance
In 2024, DaVita's revenue was $12.82 billion, an increase of 5.56% compared to the previous year's $12.14 billion. Earnings were $936.34 million, an increase of 35.40%.
Financial numbers in USD Financial StatementsNews

Berkshire Hathaway further trims DaVita stake
DaVita (NYSE:DVA) stock in focus as Berkshire Hathaway (BRK.A.) (BRK.A) further reduces its stake with insider sales worth $116.1M of share. Read more here.

Berkshire Hathaway sells another 750,000 DaVita shares
Warren Buffett's Berkshire Hathaway said it has sold an additional 750,000 shares of DaVita , reducing its stake in the kidney dialysis services provider by about 2% to 35.14 million shares worth $5.4...
DaVita Inc (DVA) Celebrates Record Participation in Annual Fundraising Event
DaVita Inc (DVA) Celebrates Record Participation in Annual Fundraising Event

Here’s why this Warren Buffett stock plunged 11% in a day
Shares of Davita Inc. (NYSE: DVA) plunged 11% on February 14, as the dialysis provider issued a weaker-than-expected 2025 earnings … Continue reading The post Here’s why this Warren Buffett stock plun...
DaVita (DVA) Stock Drops Following Earnings Report and Stake Reduction
DaVita (DVA) Stock Drops Following Earnings Report and Stake Reduction

Why DaVita Inc Stock Is Plummeting Today
DaVita (DVA) Stock Declines Amid Weak Q4 Results
DaVita (DVA) Stock Declines Amid Weak Q4 Results

DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.
DaVita shares were tumbling 13.5% Friday to lead S&P 500 decliners, after Warren Buffett's Berkshire Hathaway pared its stake in the provider of kidney dialysis.
DaVita (DVA) Shares Decline as Berkshire Hathaway Reduces Stake
DaVita (DVA) Shares Decline as Berkshire Hathaway Reduces Stake

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance
DaVita shares tumbled after issuing a weak outlook amid rising care costs, while big investor Berkshire offloaded some shares in a pre-planned agreement.

DaVita Plunges Over 10% In Friday Pre-Market After Warren Buffett Cuts Stake In One Of Berkshire Hathaway's Longest-Held Investments
The shares of DaVita Inc .(NYSE: DVA) plunged 10.2% in pre-market hours trading on Friday after Berkshire Hathaway trimmed its stake in the company. The dialysis provider also issued a weak outlook f...
DaVita Inc (DVA) Q4 2024 Earnings Call Highlights: Strong EPS Growth Amid Supply Chain Challenges
DaVita Inc (DVA) Q4 2024 Earnings Call Highlights: Strong EPS Growth Amid Supply Chain Challenges

Warren Buffett's Berkshire Hathaway Sells Nearly $36 Million Worth Of Dialysis Giant DaVita's Shares Amid Q4 Earnings Beat
Warren Buffett 's Berkshire Hathaway Inc. (NYSE: BRK) (NYSE: BRK) has cut its stake in the dialysis provide DaVita Inc. (NYSE: DVA) according to a U.S. Securities Exchange Commission filing. What H...
Warren Buffett's Recent Transaction with DaVita Inc: A Strategic Portfolio Adjustment
Warren Buffett's Recent Transaction with DaVita Inc: A Strategic Portfolio Adjustment

DaVita (DVA) Q4 2024 Earnings Call Transcript
DVA earnings call for the period ending December 31, 2024.
DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript

Berkshire sells some DaVita shares, cuts stake to 45%
Berkshire Hathaway said on Thursday night it sold 203,091 shares of DaVita , reducing its stake in the kidney dialysis services provider to about 35.89 million shares, a 45% stake worth nearly $6.4 bi...

DaVita forecasts 2025 profit below estimates, shares plummet
Dialysis firm DaVita projected annual profit below estimates on Thursday due to rising patient care costs, sending its shares down 11% in after-hours trading.
DaVita Inc (DVA) Q4 2024 Earnings: EPS of $3.09 Beats Estimate, Revenue Hits $3. ...
DaVita Inc (DVA) Q4 2024 Earnings: EPS of $3.09 Beats Estimate, Revenue Hits $3.295 Billion Surpassing Expectations

DaVita Inc. 4th Quarter 2024 Results
DENVER , Feb. 13, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended December 31, 2024. "Despite a year with unique hurdles, we finished stron...

DaVita: Momentum Could Fade Given High Valuation
DaVita stock is currently trading at a premium compared to the historical average. Click here to see why DVA stock is a Hold.

DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call
DENVER , Jan. 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 13, 2025, at 5:0...
Barclays' Andrew Mok: Any sustained underperformance in big tech will likely benefit healthcare
Andrew Mok, Barclays director of equity research, joins CNBC's 'The Exchange' to discuss why healthcare may offer opportunity as tech stocks are under pressure from China competition.
DaVita Inc Celebrates 25 Years of Transformative Kidney Care
DaVita Inc Celebrates 25 Years of Transformative Kidney Care

DaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney Health
DENVER , Jan. 15, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care provider, is celebrating 25 years of clinical care delivery and leadership in healthcare innovation. Since forming with a pur...